Trials / Completed
CompletedNCT06132529
A Study to Evaluate Biomarker Signature to Predict the Persistence of Post-traumatic Headache
Biomarker Signature to Predict the Persistence of Post-traumatic Headache
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 151 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to develop a model to help distinguish patients at high-risk for developing persistent post-traumatic headache from patients who experience headache recovery. Researchers will do this by comparing the brain images, clinical data, and speech of healthy controls to people who have been diagnosed with post-traumatic headache.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Brain Magnetic Resonance Imaging (MRI) Scan | Imaging of the brain |
| OTHER | Speech Sample | Recorded reading aloud of pre-written words and sentences |
| OTHER | Electronic Daily Headache Diary | Headache diary to provide information about headaches experience that day. |
Timeline
- Start date
- 2019-06-03
- Primary completion
- 2025-07-31
- Completion
- 2025-07-31
- First posted
- 2023-11-15
- Last updated
- 2025-08-29
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06132529. Inclusion in this directory is not an endorsement.